User profiles for M. Qadan

Motaz Qadan

- Verified email at mgh.harvard.edu - Cited by 4922

Mahmoud Qadan

- Verified email at univ.haifa.ac.il - Cited by 1163

Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials

M Qadan, O Akça, SS Mahid, CA Hornung… - Archives of …, 2009 - jamanetwork.com
… interpretation of data: Qadan, Akça, Hornung, and Polk. Drafting of the manuscript: Qadan
and Mahid. Critical revision of the manuscript for important intellectual content: Qadan, Akça, …

Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

…, DP Ryan, CD Weekes, CR Ferrone, M Qadan… - Nature …, 2022 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal and treatment-refractory cancer.
Molecular stratification in pancreatic cancer remains rudimentary and does not yet inform …

Economic analysis of batch and continuous biopharmaceutical antibody production: A review

O Yang, M Qadan, M Ierapetritou - Journal of pharmaceutical innovation, 2020 - Springer
… of $371 M ($64 M for mAbs and $306 M for non-mAbs) during a 15 years’ investment. Arnold
et al. [67] compared integrated continuous antibody production with batch processing using …

A common framework for integrated and continuous biomanufacturing

…, U Patil, D Pollard, M Qadan… - Biotechnology and …, 2021 - Wiley Online Library
… The difference in cost is about $23 M versus $0.8 M, assuming $15,000/L as a reference
point. The 25 L columns reach their lifetime in 200 cycles, or at the end of every 500 kg batch; …

Minimal residual disease detection using a plasma-only circulating tumor DNA assay in patients with colorectal cancer

…, TS Hong, L Bordeianou, CR Ferrone, M Qadan… - Clinical Cancer …, 2021 - AACR
Purpose: Detection of persistent circulating tumor DNA (ctDNA) after curative-intent surgery
can identify patients with minimal residual disease (MRD) who will ultimately recur. Most …

Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical …

…, JE Faris, AX Zhu, L Goyal, DL Berger, M Qadan… - JAMA …, 2019 - jamanetwork.com
… /m 2 bolus on day 1, then as a 2400-mg/m 2 continuous infusion for 46 hours. Leucovorin
calcium, 400 mg/m 2 ; oxaliplatin, 85 mg/m 2 ; … Dr Qadan reported personal fees from Olympus …

Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX

…, JE Murphy, RD Nipp, A Parikh, M Qadan… - Annals of …, 2019 - journals.lww.com
… of 400 mg/m 2 , bolus leucovorin 400 mg/m 2 , followed by continuous infusion at 1200 mg/m
2 per day for 46 hours, oxaliplatin 85 mg/m 2 , and irinotecan 180 mg/m 2 . Chemoradiation …

Investor sentiment and the price of oil

M Qadan, H Nama - energy economics, 2018 - Elsevier
The literature on oil prices considers real economic factors as the main drivers of changes in
oil prices. Using parametric and nonparametric methods, this study provides evidence that …

[HTML][HTML] COVID-19, government measures and hospitality industry performance

DY Aharon, A Jacobi, E Cohen, J Tzur, M Qadan - PloS one, 2021 - journals.plos.org
This study explores the interplay between public measures adopted by the US government
to combat COVID-19 and the performance of the American hospitality industry. The recent …

Intra-arterial tumor necrosis factor-α impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans

S Chia, M Qadan, R Newton, CA Ludlam… - … , and vascular biology, 2003 - Am Heart Assoc
Objective— Inflammation contributes to the pathogenesis of cardiovascular disease, potentially
through the actions of proinflammatory cytokines. We assessed the direct effects of local …